The affective dimension of pain as a risk factor for drug and alcohol addiction

作者: Dana M. LeBlanc , M. Adrienne McGinn , Christy A. Itoga , Scott Edwards

DOI: 10.1016/J.ALCOHOL.2015.04.005

关键词:

摘要: Addiction, or substance use disorder (SUD), is a devastating psychiatric disease composed of multiple elemental features. As biobehavioral disorder, escalation drug and/or alcohol intake both cause and consequence molecular neuroadaptations in central brain reinforcement circuitry. Multiple mesolimbic areas mediate host negative affective motivational symptoms that appear to be the addiction process. Brain stress- reinforcement-related regions such as amygdala (CeA), prefrontal cortex (PFC), nucleus accumbens (NAc) also serve processors ascending nociceptive input. We hypothesize sensitization mechanisms underlying processing persistent maladaptive pain contributes composite state drive enduring, relapsing nature addiction, particularly case opioid disorder. At neurochemical level, activates stress-related neuropeptide signaling, including dynorphin corticotropin-releasing factor (CRF) systems, by this process may facilitate affect escalated over time. Importantly, widespread prevalence unresolved associated dysregulation clinical populations highlights need for more effective analgesic medications with reduced potential tolerance dependence. The burgeoning epidemic prescription abuse demands closer investigation into neurobiological how treatment could potentially represent significant risk vulnerable populations. Finally, continuing convergence sensory neuroscience fields expected generate insight critical balance between relief liability, well provide therapeutic strategies chronic addiction.

参考文章(119)
Ming-Gao Zhao, Shanelle W Ko, Long-Jun Wu, Hiroki Toyoda, Hui Xu, Jessica Quan, Jianguo Li, Yongheng Jia, Ming Ren, Zao C Xu, Min Zhuo, Enhanced presynaptic neurotransmitter release in the anterior cingulate cortex of mice with chronic pain. The Journal of Neuroscience. ,vol. 26, pp. 8923- 8930 ,(2006) , 10.1523/JNEUROSCI.2103-06.2006
Yu Fu, Jeong Han, Titilope Ishola, Michelle Scerbo, Hita Adwanikar, Cara Ramsey, Volker Neugebauer, PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Molecular Pain. ,vol. 4, pp. 26- 26 ,(2008) , 10.1186/1744-8069-4-26
Evelyne Célèrier, Jean-Paul Laulin, Jean-Benoı̂t Corcuff, Michel Le Moal, Guy Simonnet, Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process. The Journal of Neuroscience. ,vol. 21, pp. 4074- 4080 ,(2001) , 10.1523/JNEUROSCI.21-11-04074.2001
Volker Neugebauer, Weidong Li, Gary C. Bird, Jeong S. Han, The Amygdala and Persistent Pain The Neuroscientist. ,vol. 10, pp. 221- 234 ,(2004) , 10.1177/1073858403261077
Matthew J. Bair, Rebecca L. Robinson, Wayne Katon, Kurt Kroenke, Depression and Pain Comorbidity Archives of Internal Medicine. ,vol. 163, pp. 2433- 2445 ,(2003) , 10.1001/ARCHINTE.163.20.2433
Ajay D Wasan, Edgar L Ross, Edward Michna, Lori Chibnik, Shelly F Greenfield, Roger D Weiss, Robert N Jamison, None, Craving of Prescription Opioids in Patients With Chronic Pain: A Longitudinal Outcomes Trial The Journal of Pain. ,vol. 13, pp. 146- 154 ,(2012) , 10.1016/J.JPAIN.2011.10.010
Alan I. Leshner, Addiction Is a Brain Disease, and It Matters Science. ,vol. 278, pp. 45- 47 ,(1997) , 10.1126/SCIENCE.278.5335.45
Jennifer Y. Xie, Chaoling Qu, Amol Patwardhan, Michael H. Ossipov, Edita Navratilova, Lino Becerra, David Borsook, Frank Porreca, Activation of mesocorticolimbic reward circuits for assessment of relief of ongoing pain: a potential biomarker of efficacy. Pain. ,vol. 155, pp. 1659- 1666 ,(2014) , 10.1016/J.PAIN.2014.05.018
M. Ericsson, W. S. C. Poston II, Jürgen Linder, Jennifer E. Taylor, C. Keith Haddock, John P. Foreyt, Depression predicts disability in long-term chronic pain patients Disability and Rehabilitation. ,vol. 24, pp. 334- 340 ,(2002) , 10.1080/09638280110096241
Scott Edwards, George F Koob, Neurobiology of dysregulated motivational systems in drug addiction Future Neurology. ,vol. 5, pp. 393- 401 ,(2010) , 10.2217/FNL.10.14